Free Trial

Compare Stocks

Compare stocks with our powerful stock comparison tool. Analyze fundamentals, price performance, and key financial indicators to make informed investment decisions. Our tool lets you compare up to ten stocks side by side based on Performance Charts, Price & Volume, MarketRank™, Analyst Ratings, Sales & Book Value, Profitability & Earnings, Dividends, Debt, Ownership, Headlines, and more. Simply enter up to ten stock symbols (e.g., BAC, JPM, WFC, C, GS) to get started and uncover top investment opportunities.

CompanyCurrent Price50-Day Moving Average52-Week RangeMarket CapBetaAvg. VolumeToday's Volume
Glaukos Corporation stock logo
GKOS
Glaukos
$96.97
-0.7%
$98.28
$77.10
$163.71
$5.58B0.82747,887 shs618,759 shs
Penumbra, Inc. stock logo
PEN
Penumbra
$228.19
-0.9%
$258.27
$148.00
$310.00
$8.92B0.47456,276 shs567,165 shs
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€24.35
-2.2%
€24.04
€17.12
€26.50
€7.37B0.55326,667 shs142,500 shs
Warby Parker Inc. stock logo
WRBY
Warby Parker
$24.35
+1.7%
$21.23
$12.46
$28.68
$2.50B2.092.01 million shs2.15 million shs
(Almost)  Everything You Need To Know About The EV Market Cover

Looking to profit from the electric vehicle mega-trend? Enter your email address and we'll send you our list of which EV stocks show the most long-term potential.

Get This Free Report

Compare Price Performance

Company1-Day Performance7-Day Performance30-Day Performance90-Day Performance1-Year Performance
Glaukos Corporation stock logo
GKOS
Glaukos
0.00%-5.71%-2.56%+10.88%-19.03%
Penumbra, Inc. stock logo
PEN
Penumbra
0.00%-3.06%-10.38%-14.94%+21.19%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.00%-0.87%+6.67%+15.20%+16.65%
Warby Parker Inc. stock logo
WRBY
Warby Parker
0.00%+7.75%+10.16%+69.77%+51.49%
CompanyOverall ScoreAnalyst's OpinionShort Interest ScoreDividend StrengthESG ScoreNews and Social Media SentimentCompany OwnershipEarnings & Valuation
Glaukos Corporation stock logo
GKOS
Glaukos
4.4534 of 5 stars
4.41.00.04.43.31.70.6
Penumbra, Inc. stock logo
PEN
Penumbra
4.8132 of 5 stars
4.52.00.03.73.02.51.9
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/AN/AN/AN/AN/AN/AN/AN/A
Warby Parker Inc. stock logo
WRBY
Warby Parker
2.8744 of 5 stars
2.35.00.00.02.83.30.6
CompanyConsensus Rating ScoreConsensus RatingConsensus Price Target% Upside from Current Price
Glaukos Corporation stock logo
GKOS
Glaukos
2.75
Moderate Buy$134.6738.87% Upside
Penumbra, Inc. stock logo
PEN
Penumbra
2.94
Moderate Buy$305.0733.69% Upside
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
2.86
Moderate BuyN/AN/A
Warby Parker Inc. stock logo
WRBY
Warby Parker
2.53
Moderate Buy$22.88-6.05% Downside

Current Analyst Ratings Breakdown

Latest WRBY, PEN, STVN, and GKOS Analyst Ratings

DateCompanyBrokerageActionRatingPrice TargetDetails
7/18/2025
Penumbra, Inc. stock logo
PEN
Penumbra
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
UpgradeStrong-Buy
7/14/2025
Glaukos Corporation stock logo
GKOS
Glaukos
BTIG Research
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
7/10/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
JMP Securities
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingMarket Outperform ➝ Market Perform
7/10/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Citizens Jmp
Subscribe to MarketBeat All Access for the recommendation accuracy rating
DowngradeOutperform ➝ Market Perform
7/9/2025
Penumbra, Inc. stock logo
PEN
Penumbra
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Lower Price TargetNeutral ➝ Neutral$320.00 ➝ $285.00
6/30/2025
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
William Blair
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOutperform
5/29/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Piper Sandler
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingOverweight ➝ Overweight$20.00 ➝ $25.00
5/22/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Roth Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$18.00 ➝ $21.00
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Cowen
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Loop Capital
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingBuy ➝ Buy
5/21/2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
Citigroup
Subscribe to MarketBeat All Access for the recommendation accuracy rating
Reiterated RatingNeutral ➝ Neutral$17.00 ➝ $22.00
(Data available from 7/21/2022 forward. View 10+ years of historical ratings with our analyst ratings screener.)
CompanyAnnual RevenuePrice/SalesCashflowPrice/CashBook ValuePrice/Book
Glaukos Corporation stock logo
GKOS
Glaukos
$383.48M14.45N/AN/A$13.91 per share6.97
Penumbra, Inc. stock logo
PEN
Penumbra
$1.19B7.40$2.86 per share79.81$29.99 per share7.61
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€1.19B6.17€0.74 per share32.99€5.02 per share4.85
Warby Parker Inc. stock logo
WRBY
Warby Parker
$771.32M3.30$0.35 per share70.49$3.35 per share7.27
CompanyNet IncomeEPSTrailing P/E RatioForward P/E RatioP/E GrowthNet MarginsReturn on Equity (ROE)Return on Assets (ROA)Next Earnings Date
Glaukos Corporation stock logo
GKOS
Glaukos
-$146.37M-$2.37N/AN/AN/A-31.40%-10.66%-8.06%7/30/2025 (Estimated)
Penumbra, Inc. stock logo
PEN
Penumbra
$14.01M$1.06215.2845.552.063.41%11.14%8.40%7/29/2025 (Estimated)
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
€127.45M€0.5147.7541.982.3811.14%10.00%6.03%N/A
Warby Parker Inc. stock logo
WRBY
Warby Parker
-$20.39M-$0.12N/A243.48N/A-1.79%-2.48%-1.29%8/7/2025 (Confirmed)

Latest WRBY, PEN, STVN, and GKOS Earnings

DateQuarterCompanyConsensus EstimateReported EPSBeat/MissGap EPSRevenue EstimateActual RevenueDetails
8/7/2025Q2 2025
Warby Parker Inc. stock logo
WRBY
Warby Parker
$0.09N/AN/AN/A$212.42 millionN/A
7/30/2025Q2 2025
Glaukos Corporation stock logo
GKOS
Glaukos
-$0.26N/AN/AN/A$115.49 millionN/A
7/29/2025Q2 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.81N/AN/AN/A$327.37 millionN/A
4/30/2025Q1 2025
Glaukos Corporation stock logo
GKOS
Glaukos
-$0.33-$0.22+$0.11-$0.32$102.78 million$106.66 million
4/23/2025Q1 2025
Penumbra, Inc. stock logo
PEN
Penumbra
$0.66$0.83+$0.17$1.00$315.72 million$324.14 million
CompanyAnnual PayoutDividend Yield3-Year Dividend GrowthPayout RatioYears of Consecutive Growth
Glaukos Corporation stock logo
GKOS
Glaukos
N/AN/AN/AN/AN/A
Penumbra, Inc. stock logo
PEN
Penumbra
N/AN/AN/AN/AN/A
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/AN/AN/AN/A1 Years
Warby Parker Inc. stock logo
WRBY
Warby Parker
N/AN/AN/AN/AN/A

Latest WRBY, PEN, STVN, and GKOS Dividends

AnnouncementCompanyPeriodAmountYieldEx-Dividend DateRecord DatePayable Date
5/2/2025
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
annual€0.060.3%6/5/20256/5/20257/17/2025
(Data available from 1/1/2013 forward)
CompanyDebt-to-Equity RatioCurrent RatioQuick Ratio
Glaukos Corporation stock logo
GKOS
Glaukos
0.09
6.49
5.62
Penumbra, Inc. stock logo
PEN
Penumbra
0.02
6.30
3.68
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
0.22
1.83
1.26
Warby Parker Inc. stock logo
WRBY
Warby Parker
N/A
2.70
2.30

Institutional Ownership

CompanyInstitutional Ownership
Glaukos Corporation stock logo
GKOS
Glaukos
99.04%
Penumbra, Inc. stock logo
PEN
Penumbra
88.88%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/A
Warby Parker Inc. stock logo
WRBY
Warby Parker
93.24%

Insider Ownership

CompanyInsider Ownership
Glaukos Corporation stock logo
GKOS
Glaukos
6.40%
Penumbra, Inc. stock logo
PEN
Penumbra
5.00%
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
N/A
Warby Parker Inc. stock logo
WRBY
Warby Parker
18.24%
CompanyEmployeesShares OutstandingFree FloatOptionable
Glaukos Corporation stock logo
GKOS
Glaukos
78057.14 million53.48 millionOptionable
Penumbra, Inc. stock logo
PEN
Penumbra
4,50038.73 million36.79 millionOptionable
Stevanato Group S.p.A. stock logo
STVN
Stevanato Group
5,521302.84 millionN/AOptionable
Warby Parker Inc. stock logo
WRBY
Warby Parker
3,780104.50 million85.44 millionOptionable

Recent News About These Companies

Head to Head Comparison: Warby Parker (WRBY) & Its Rivals
Contrasting Warby Parker (WRBY) & The Competition
Warby Parker (NYSE:WRBY) Cut to Market Perform at Citizens Jmp

New MarketBeat Followers Over Time

Media Sentiment Over Time

Top Headlines

View All Headlines
Glaukos stock logo

Glaukos NYSE:GKOS

$96.97 -0.73 (-0.74%)
Closing price 03:58 PM Eastern
Extended Trading
$96.84 -0.13 (-0.14%)
As of 05:27 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Glaukos Corporation, an ophthalmic pharmaceutical and medical technology company, focuses on the development of novel therapies for the treatment of glaucoma, corneal disorders, and retinal diseases. It offers iStent and iStent inject W micro-bypass stents that enhance aqueous humor outflow inserted in cataract surgery to treat mild-to-moderate open-angle glaucoma. The company's product pipeline includes iStent Infinite indicated for use in the treatment of patients with glaucoma uncontrolled by prior medical and surgical therapy; and iDose TR, an intracameral procedural pharmaceutical therapy indicated for the reduction of intraocular pressure in patients with open-angle glaucoma or ocular hypertension. The company markets its products through direct sales organization, as well as through distributors in the United States and internationally. Glaukos Corporation was incorporated in 1998 and is headquartered in Aliso Viejo, California.

Penumbra stock logo

Penumbra NYSE:PEN

$228.19 -2.19 (-0.95%)
Closing price 03:58 PM Eastern
Extended Trading
$228.30 +0.10 (+0.04%)
As of 06:00 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Penumbra, Inc., together with its subsidiaries, designs, develops, manufactures, and markets medical devices in the United States and internationally. The company offers peripheral products, including the Indigo System for power aspiration of thrombus in the body; Lightning Flash, a mechanical thrombectomy system; Lightning Bolt 7, an arterial thrombectomy system; and CAT RX. It also provides access products, including guide catheters and the Penumbra distal delivery catheters under the Neuron, Neuron MAX Select, BENCHMARK, BMX96, BMX81, DDC, SENDit, and PX SLIM brands; Penumbra System, an integrated mechanical thrombectomy system comprising reperfusion catheters and separators, the 3D Revascularization Device, aspiration tubing, and aspiration pump under the Penumbra RED, JET, ACE, Max, 3D Revascularization Device, and Penumbra ENGINE brands; and neuro embolization coiling systems that includes the Penumbra Coil 400, a detachable coil that provides an alternative for the treatment of aneurysms and other complex lesions, as well as Penumbra SMART COIL, a detachable coil to treat patients with a wide range of neurovascular lesions; and POD400 and PAC400 brands. In addition, the company provides peripheral embolization products, such as Ruby Coil System consisting of detachable coils for peripheral applications; Penumbra LANTERN Delivery Microcatheter, a low-profile microcatheter with a high-flow lumen; POD (Penumbra Occlusion Device) System, a single device solution; and Packing Coil, a complementary device for use in other peripheral embolization products. Further, it offers an immersive 3D computer-based technology platform under the real immersive system brand; and neurosurgical tools, such as Artemis Neuro Evacuation Device for surgical removal of fluid and tissue from the ventricles and cerebrum. The company sells its products through direct sales organizations and distributors. Penumbra, Inc. was incorporated in 2004 and is headquartered in Alameda, California.

Stevanato Group stock logo

Stevanato Group NYSE:STVN

€24.35 -0.55 (-2.21%)
As of 03:54 PM Eastern

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.

Warby Parker stock logo

Warby Parker NYSE:WRBY

$24.35 +0.42 (+1.75%)
Closing price 03:58 PM Eastern
Extended Trading
$24.18 -0.17 (-0.71%)
As of 07:58 PM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Polygon.io. Learn more.

Warby Parker Inc. provides eyewear products in the United States and Canada. The company offers eyeglasses, sunglasses, light-responsive lenses, blue-light-filtering lenses, non-prescription lenses, and contact lenses. It also provides accessories, such as cases, lenses kit with anti-fog spray, pouches, and anti-fog lens spray through its retail stores, website, and mobile apps. In addition, the company offers eye exams and vision tests. Warby Parker Inc. was incorporated in 2009 and is headquartered in New York, New York.